Cargando…
Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators
Parkinson’s disease (PD) is characterized by the presence of Lewy bodies and degeneration of dopaminergic neurons. 1-methyl-4-phenylpyridinium (MPP+), a metabolite of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Lewy body component α-synuclein activates glia in PD pathogenesis....
Autores principales: | Kempuraj, Duraisamy, Thangavel, Ramasamy, Yang, Evert, Pattani, Sagar, Zaheer, Smita, Santillan, Donna A., Santillan, Mark K., Zaheer, Asgar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537263/ https://www.ncbi.nlm.nih.gov/pubmed/26275153 http://dx.doi.org/10.1371/journal.pone.0135776 |
Ejemplares similares
-
Glia Maturation Factor and Mitochondrial Uncoupling Proteins 2 and 4 Expression in the Temporal Cortex of Alzheimer’s Disease Brain
por: Thangavel, Ramasamy, et al.
Publicado: (2017) -
Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer’s Disease
por: Kempuraj, Duraisamy, et al.
Publicado: (2019) -
Mast Cell Activation, Neuroinflammation, and Tight Junction Protein Derangement in Acute Traumatic Brain Injury
por: Kempuraj, Duraisamy, et al.
Publicado: (2020) -
Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis
por: Kempuraj, Duraisamy, et al.
Publicado: (2017) -
Absence of Glia Maturation Factor Protects from Axonal
Injury and Motor Behavioral Impairments after
Traumatic Brain Injury
por: Selvakumar, Govindhasamy Pushpavathi, et al.
Publicado: (2020)